Starpharma company secretary retires this week
Starpharma (ASX:SPL) has announced the imminent retirement of long-serving company secretary Ben Rogers.
Rogers will be replaced on Friday by Starpharma CFO Nigel Baade, who has been with the company for seven years.
Starpharma CEO Dr Jackie Fairley said Rogers and Baade have been working together closely for the past seven years, meaning the transition should be painless.
“As an executive team we have worked closely with Ben over many years and the executive and the board thank him for his valuable contribution,” Fairley said. “We are fortunate to have had a natural choice in Nigel to succeed Ben in the position of Company Secretary.”
In September, Starpharma revealed it was developing a new dendrimer-enhanced chemotherapy drug, dendrimer oxaliplatin. The company’s first dendrimer-enhanced chemotherapy, dendrimer docetaxel, is at the phase I trial stage.
Starpharma (ASX:SPL) shares were trading 2.26% lower at $0.777 as of around 1 pm on Tuesday.
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
Immune cell boost could enable lasting vaccine protection
A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...
Genes influence when babies start walking
Genetics accounts for about a quarter of the differences in when children take their first steps,...
